Kestra Medical Technologies, Ltd. KMTS NASDAQ

NASDAQ Global Select • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score

49/100

2/7 Pass

SharesGrow Intrinsic Value

Income Statement Balance Sheet Cash Flow Statement

Annual Quarterly

Kestra Medical Technologies, Ltd. (KMTS) generated $-18.37M in operating cash flow for quarter ending 2026-01-31. After capital expenditures of $9.8M, free cash flow was $-28.16M.

Free cash flow margin was -114.7% of revenue. Cash conversion ratio was 0.54x, suggesting some earnings are non-cash.

The company returned $25K in dividends to shareholders during the quarter.

Criteria supported by this page:

HEALTH (67/100, Partial) — cash generation is adequate but may not fully cover debt in stressed conditions
MOAT (55/100, Partial) — cash flow generation is present but not at levels indicating a wide moat
INCOME (10/100) — Cash conversion ratio was 0.54x suggests some earnings are non-cash items

Overall SharesGrow Score: 49/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score

49/100

SG Score

View full scorecard →

✓

VALUE

71/100

Price-to-Earnings & upside

→ Valuation

✓

FUTURE

85/100

Analyst consensus

→ Forecast

✗

PAST

0/100

→ Income

HEALTH

67/100

Debt-to-Equity & liquidity

Proven by this page

MOAT

55/100

Proven by this page

GROWTH

58/100

→ Income

✗

INCOME

10/100

→ Income

Kestra Medical Technologies, Ltd. Cash Flow History

Metric	TTM	Q3 FY2026	Q2 FY2026	Q1 FY2026	Q4 FY2025
Operating Cash Flow	$-86.68M	$-18.37M	$-18.34M	$-26.27M	$-23.7M
Capital Expenditure	$-33.27M	$-9.8M	$-7.27M	$-8.17M	$-8.04M
Free Cash Flow	$-119.95M	$-28.16M	$-25.61M	$-34.44M	$-31.74M